$-0.03 EPS Expected for Theratechnologies Inc. (TH)

June 20, 2018 - By Alfred Lee

Analysts expect Theratechnologies Inc. (TSE:TH) to report $-0.03 EPS on July, 11.They anticipate $0.10 EPS change or 76.92 % from last quarter’s $-0.13 EPS. After having $-0.04 EPS previously, Theratechnologies Inc.’s analysts see -25.00 % EPS growth. The stock decreased 1.64% or $0.22 during the last trading session, reaching $13.19. About 54,232 shares traded. Theratechnologies Inc. (TSE:TH) has 0.00% since June 20, 2017 and is . It has underperformed by 12.57% the S&P500.

Theratechnologies Inc., specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and an enhanced life among HIV patients. The company has market cap of $1.01 billion. The Company’s lead product is EGRIFTA, which increases the incidence or progression of diabetic retinopathy in diabetic HIV-infected patients with lipodystrophy and excess abdominal fat in the United States and Canada. It currently has negative earnings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.